No Data
No Data
Standard BioTools Plans to Sell 105.1M Shares in Secondary Offering - Filing
TD Cowen Maintains Standard BioTools(LAB.US) With Buy Rating, Maintains Target Price $3.5
TD Cowen analyst Daniel Brennan maintains $Standard BioTools(LAB.US)$ with a buy rating, and maintains the target price at $3.5.According to TipRanks data, the analyst has a success rate of 47.4% and
Express News | Standard BioTools Inc Files for Offering of up to 105.1 Mln Common Shares by the Selling Securityholders - SEC Filing
Standard BioTools(LAB.US) 10% Shareholder Buys US$260K in Common Stock
$Standard BioTools(LAB.US)$ 10% Shareholder Casdin Partners Master Fund, L.P. purchased 100K shares of common stock on May 23, 2024 at an average price of $2.6 for a total value of $260K. This transac
Express News | Standard BioTools Purchases The Carterra LSA-XT System; No Financial Terms Disclosed
Express News | Standard BioTools Purchases the Carterra® Lsa-Xt System to Accelerate Data Delivery and Provide Greater Validation to Somascan Customers
No Data